The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CHESAPEAKE ENERGY CORP | NOTE | 165167CY1 | 1,000 | 23,475,000 | PRN | SOLE | 23,475,000 | 0 | 23,475,000 | ||
| DISH NETWORK CORP | NOTE | 25470MAB5 | 14,000 | 20,300,000 | PRN | SOLE | 20,300,000 | 0 | 20,300,000 | ||
| LIBERTY MEDIA CORP | DEB | 530715AG6 | 26,000 | 47,700,000 | PRN | SOLE | 47,700,000 | 0 | 47,700,000 | ||
| LIBERTY MEDIA CORP | DEB | 530715AL5 | 5,000 | 9,500,000 | PRN | SOLE | 9,500,000 | 0 | 9,500,000 | ||
| TEVA PHARMACEUTICAL FIN LLC | DBCV | 88163VAE9 | 5,000 | 5,500,000 | PRN | SOLE | 5,500,000 | 0 | 5,500,000 | ||
| AMBAC FINL GROUP INC | COM | 023139884 | 3,000 | 199,300 | SH | SOLE | 199,300 | 0 | 199,300 | ||
| CLEAR CHANNEL OUTDOOR HLDGS | COM | 18453H106 | 500 | 756,426 | SH | SOLE | 756,426 | 0 | 756,426 | ||
| DISH NETWORK CORPORATION | COM | 25470M109 | 9,000 | 400,000 | SH | SOLE | 400,000 | 0 | 400,000 | ||
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 1,000 | 428,571 | SH | SOLE | 428,571 | 0 | 428,571 | ||
| NIELSEN HOLDINGS | SHS EUR | G6518L108 | 7,000 | 530,000 | SH | SOLE | 530,000 | 0 | 530,000 | ||
| ISHARES TR | IBOXX HI YD ETF | 464288513 | 2,000 | 26,591 | SH | SOLE | 26,591 | 0 | 26,591 | ||
| ISHARES TR | IBOXX HI YD ETF | 464288513 | 362,000 | 4,650,000 | SH | Put | SOLE | 4,650,000 | 0 | 4,650,000 | |
| ISHARES TR | IBOXX HI YD ETF | 464288513 | 116,000 | 1,500,000 | SH | Call | SOLE | 1,500,000 | 0 | 1,500,000 | |